Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Marilyn J. Manco‐Johnson, Thomas C. Abshire, Amy D. Shapiro et al. · New England Journal of Medicine · 2007 · 1.9K citations · Full text

Conformation Changes of Proteins

Rufus Lumry, Henry Eyring · The Journal of Physical Chemistry · 1954 · 864 citations

Protein Assembly, Databases, Altmetric Attention Score +22

Rational Design of a Potent, Long-Lasting Form of Interferon:  A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C

Pascal Bailon, Alicia V. Palleroni, Carol Ann Schaffer et al. · Bioconjugate Chemistry · 2001 · 609 citations

Interferon Alpha-2a, Translational Medicine, Ethylene Glycol +15

Chemistry of polyethylene glycol conjugates with biologically active molecules

Samuel Zalipsky · Advanced Drug Delivery Reviews · 1995 · 548 citations

Synthetic Macromolecule, Engineering, Natural Polymer +4

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen et al. · Journal of Thrombosis and Haemostasis · 2007 · 325 citations · Full text

Thrombosis, Secondary Prophylaxis, Hematology +10